everolimus
Showing 1 - 25 of 435
Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)
Not yet recruiting
- Meningioma
- Everolimus
-
Vandœuvre-lès-Nancy, Grand Est, France
- +1 more
Nov 8, 2023
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of
Not yet recruiting
- Triple Negative Breast Cancer
- +2 more
- Everolimus
- Investigator's Choice of Chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 25, 2023
Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)
Active, not recruiting
- Classical Hodgkin Lymphoma
- Itacitinib
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 28, 2022
Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)
Active, not recruiting
- Advanced Cancers
- Solid Tumors
- Pazopanib
- Everolimus
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Epilepsy Trial in Shenyang (Everolimus, Placebo)
Recruiting
- Epilepsy
- Everolimus
- Placebo
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Nov 5, 2022
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Completed
- Glioblastoma Multiforme
- Glioma of Brain
- Ribociclib
- Everolimus
-
Chandler, Arizona
- +2 more
Jan 11, 2023
Uterine Sarcoma Trial (Everolimus)
Available
- Uterine Sarcoma
- Everolimus
- (no location specified)
Aug 25, 2022
Kidney Transplant Infection, BK Virus Infection Trial in Bangkok (Everolimus, reduced dose tacrolimus)
Recruiting
- Kidney Transplant Infection
- BK Virus Infection
- Everolimus
- reduced dose tacrolimus
-
Bangkok, ThailandKing Chulalongkorn Memorial Hospital
Nov 10, 2022
Aging Trial in Madison (Sirolimus, Everolimus)
Not yet recruiting
- Aging
- Sirolimus
- Everolimus
-
Madison, WisconsinUniversity of Wisconsin
Jul 17, 2023
Thymoma and Thymic Carcinoma Trial in Rozzano (Everolimus)
Completed
- Thymoma and Thymic Carcinoma
- Everolimus
-
Rozzano, MI, ItalyIstituto Clinico Humanitas
Sep 8, 2022
Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2022
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
- Dasatinib
- Everolimus
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Sep 26, 2022
Renal Angiomyolipoma Trial (Everolimus)
Not yet recruiting
- Renal Angiomyolipoma
- Everolimus
- (no location specified)
Aug 15, 2022
Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)
Not yet recruiting
- Metastatic Midgut Neuroendocrine Tumor
- Unresectable Midgut Neuroendocrine Tumor
- Biospecimen Collection
- +5 more
- (no location specified)
Mar 16, 2023
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
- Everolimus
- Lenvatinib
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)
Completed
- Diffuse Intrinsic Pontine Glioma
- +6 more
- ribociclib
- Everolimus
-
Washington, District of Columbia
- +6 more
Jan 12, 2023
Gastrointestinal Stromal Tumor Trial (Everolimus)
Temporarily not available
- Gastrointestinal Stromal Tumor
- Everolimus
- (no location specified)
May 5, 2022
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)
Recruiting
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Everolimus
- +3 more
-
Atlanta, Georgia
- +3 more
Aug 18, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022
Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)
Recruiting
- Renal Cell Carcinoma
- Lenvatinib
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
May 4, 2022
Breast Cancer Stage IIB Trial in Philadelphia (Hydroxychloroquine, Everolimus)
Recruiting
- Breast Cancer Stage IIB
- Hydroxychloroquine
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 8, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
- Ribociclib
- Everolimus
-
Aurora, Colorado
- +17 more
May 2, 2023
Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)
Completed
- Acute Lymphoblastic Leukemia
- Everolimus
- +5 more
-
San Francisco, California
- +7 more
Aug 5, 2022